Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.310, 2001-01, pp. : 3-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Tacrolimus worth the extra cost in kidney transplantation
Inpharma, Vol. 1, Iss. 1289, 2001-01 ,pp. :
Access to resources
Recommend
Amifostine worth extra cost in treating solid tumours
Inpharma, Vol. 1, Iss. 1281, 2001-01 ,pp. :
Amifostine worth extra cost in treating solid tumours
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 306, 2001-01 ,pp. :
Extending US Medicare coverage worth it in kidney transplantation
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 467, 2004-01 ,pp. :
Tacrolimus rejects sirolimus for MMF in kidney transplantation
Inpharma, Vol. 1, Iss. 1553, 2006-01 ,pp. :